X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/revopsis-secures-16-5-million-seed-funding-to-advance-first-in-class-tri-specific-therapy-for-neovascular-amd-treatment-302127081.html
https://www.globenewswire.com/news-release/2023/04/11/2644361/0/en/Shockwave-Medical-Completes-Acquisition-of-Neovasc.html
https://www.globenewswire.com/news-release/2023/03/31/2639027/0/en/Neovasc-Announces-Fourth-Quarter-and-Fiscal-Year-2022-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2023/03/06/2621604/0/en/Neovasc-Shareholders-Approve-Acquisition-by-Shockwave-Medical.html
https://www.globenewswire.com/news-release/2023/02/01/2599595/0/en/Neovasc-Announces-German-Reimbursement-Renewal.html
https://www.globenewswire.com/news-release/2023/01/17/2589887/0/en/Shockwave-Medical-Announces-Agreement-to-Acquire-Neovasc.html
https://www.globenewswire.com/news-release/2023/01/17/2589924/0/en/Shockwave-Medical-to-Acquire-Neovasc.html
https://www.fiercebiotech.com/medtech/shockwave-medicals-heart-disease-device-business-gets-jolt-100m-neovasc-buy
https://www.globenewswire.com//news-release/2022/11/28/2563567/0/en/Neovasc-Announces-Progress-on-COSIRA-II-Clinical-Trial.html
https://www.globenewswire.com/news-release/2022/11/10/2553757/0/en/Neovasc-Announces-Third-Quarter-Financial-Results-and-Provides-Corporate-Update.html
Market Place
Share 
